P667 Standard vs. intensified infliximab rescue therapy for hospitalised paediatric patients with acute severe exacerbations of colitis-predominant inflammatory bowel disease

The use of infliximab (IFX) rescue therapy for hospitalised patients with acute severe colitis is increasingly employed for steroid-refractory disease. Practice guidelines exist for acute severe ulcerative colitis (UC); however, there are no equivalent guidelines for Crohn’s disease (CD). The aim of the study was to determine the efficacy of IFX induction regimens as rescue therapy for acute severe colitis-predominant CD, UC, and indeterminate...